A Cardiovascular Risk Reduction Program for American Indians with Metabolic Syndrome: The Balance Study

Elisa T. Lee, Jared B. Jobe, Jeunliang Yeh, Tauqeer Ali, Everett R. Rhoades, Allen W. Knehans, Diane J. Willis, Melanie R. Johnson, Ying Zhang, Bryce Poolaw, Billy Rogers

The Balance Study is a randomized controlled trial designed to reduce cardiovascular disease (CVD) risk in 200 American Indian (AI) participants with metabolic syndrome who reside in southwestern Oklahoma. Major risk factors targeted include weight, diet, and physical activity. Participants are assigned randomly to one of two groups, a guided or a self-managed group. The guided group attends intervention meetings that comprise education and experience with the following components: diet, exercise, AI culture, and attention to emotional wellbeing. The self-managed group receives printed CVD prevention materials that are generally available. The duration of the intervention is 24 months. Several outcome variables will be compared between the two groups to assess the effectiveness of the intervention program.